Vascular endothelial growth factor inhibitors, pegylated human recombinant hyaluronidase-α, collagenase and angiotensin inhibitors are suggested for potential drugs which can reduce IFP and promote the delivery of various molecules into tumor tissues (165). The gene discussed is VEGFA; the disease is neoplasm.